Track topics on Twitter Track topics that are important to you
ATLANTA, Aug. 2, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming 37th Annual Canaccord Genuity Growth Conference on Thursday, August 10, 2017 at the InterContinental Boston Hotel.
A live webcast of the Company's presentation is scheduled to begin at 10:00 a.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer.
The live webcast can be accessed through CryoLife's website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.
The Ruth Group
D. Ashley Lee
Executive Vice President, Chief Financial Officer
and Chief Operating Officer
View original content with multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-37th-annual-canaccord-genuity-growth-conference-300497684.html
SOURCE CryoLife, Inc.NEXT ARTICLE
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...